SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?


To: Sonki who wrote (19121)4/19/1998 6:05:00 PM
From: Nancy  Respond to of 27012
 
s, american exchange will introduce some sector index funds by end of '98 - structured much like spy, mdy and dia - that would beat fido's sector funds.



To: Sonki who wrote (19121)4/19/1998 8:02:00 PM
From: Nancy  Read Replies (2) | Respond to of 27012
 
s, from aol pfe board

Subject: Early Viagra sales
Date: Sun, Apr 19, 1998 19:30 EDT
From: Chewiepop
Message-id: <1998041923303200.TAA09516@ladder03.news.aol.com>

As a PFE shareholder, and a pharmacist I am pleased with the high demand for Viagra. But I must temper my enthusiasm for the moment because of these factors. 1. Tremendous media hype has produced a lot of demand. The problem does exist for many. 2. There is little or no sampling of this product therefore all new use results in a written prescription...ergo more prescriptions than normal. 3. High early demand may not have as many
beneficiaries as predicted. I'm waiting for the refills to see how happy the users are with the benefits. 4. As the drug gets used beyond the 3,000 to 5,000 clinical testers the risk of unknown side effects exists. Much of this information will be available in the next few months. I hope its all positive. For me it'll be a Win-Win situation.



To: Sonki who wrote (19121)4/19/1998 8:23:00 PM
From: Nancy  Respond to of 27012
 
s,here is the SF Chronicle's article on pfe - looks like 15K daily is for real - but as the other guy said, it is the refull that matters.

btw, prozac is by lly, and it is going out of pattern by either 2001 or 2003 depends on the lawsuit lly is fighting - evista is expected to replace prozac as the gangbuster, but so far has been disappointing.
(it is evident, prozac target the whole population, while evista only has women as patients)

sfgate.com

now a cautious note (and that is what pfe is afraid of - recreational use might cause side effects unwanted and cause trouble)

jsonline.com